These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 4620442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunotherapy of malignant tumors in man].
    Govalle VI.
    Vopr Onkol; 1976; 22(3):99-109. PubMed ID: 779262
    [No Abstract] [Full Text] [Related]

  • 7. The present status of immunodiagnosis and immunotherapy of cancer.
    Pasternak G.
    Arch Geschwulstforsch; 1981; 51(4):284-93. PubMed ID: 7032448
    [Abstract] [Full Text] [Related]

  • 8. Application of transfer factor to clinical immunotherapy.
    Greco RS.
    Surg Gynecol Obstet; 1976 May; 142(5):765-78. PubMed ID: 772850
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Commentary: Current status of clinical immunotherapy.
    Bluming AZ.
    Cancer Chemother Rep; 1975 May; 59(5):901-13. PubMed ID: 1239330
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunotherapy of sarcomas.
    Leventhal BG.
    Natl Cancer Inst Monogr; 1981 Apr; (56):183-7. PubMed ID: 6170891
    [Abstract] [Full Text] [Related]

  • 15. [Immune RNA: its application in cancer immunotherapy].
    Genaro AM, Cremaschi GA.
    Acta Physiol Lat Am; 1983 Apr; 33(1):21-31. PubMed ID: 6197863
    [Abstract] [Full Text] [Related]

  • 16. [Current trends in an immunological approach in cancer therapy].
    Ishibashi Y.
    Nihon Ishikai Zasshi; 1969 Feb; 61(3):271-82. PubMed ID: 4890999
    [No Abstract] [Full Text] [Related]

  • 17. Effect of whole and lysed sensitized lymphocytes on murine tumor growth and host survival.
    Greco RS, Schmidt DR, Storer EH.
    Surg Forum; 1973 Feb; 24():109-11. PubMed ID: 4808028
    [No Abstract] [Full Text] [Related]

  • 18. Immunity in malignant disease.
    Fairley GH.
    Trans Med Soc Lond; 1968 Feb; 84():96-109. PubMed ID: 5708160
    [No Abstract] [Full Text] [Related]

  • 19. Current status of the immunotherapy of cancer.
    N Z Med J; 1974 Apr 24; 79(513):874-5. PubMed ID: 4527726
    [No Abstract] [Full Text] [Related]

  • 20. Passive immunotherapy of cancer in animals and man.
    Rosenberg SA, Terry WD.
    Adv Cancer Res; 1977 Apr 24; 25():323-88. PubMed ID: 326003
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.